A Validated Reverse-phase HPLC Analytical Method for the Quantification of Phenolic Compounds in Baccharis dracunculifolia

被引:35
作者
de Sousa, Joao Paulo B.
da Silva Filho, Ademar A. [2 ]
Bueno, Paula C. P.
Gregorio, Luiz E. [3 ]
Furtado, Niege A. J. C.
Jorge, Renata F.
Bastos, Jairo K. [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Ciencias Farmaceut, Lab Farmacognosia, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, BR-14404600 Franca, SP, Brazil
[3] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Quim & Fis, BR-14040903 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Baccharis dracunculifolia; Brazilian green propolis; HPLC; phenolic compounds; BRAZILIAN GREEN PROPOLIS; QUANTITATIVE METHOD; EXTRACTS;
D O I
10.1002/pca.1087
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Introduction - Baccharis dracunculifolia, which has great potential for the development of new phytotherapeutic medicines, is the most important botanical source of the southeastern Brazilian propolis, known as green propolis on account of its color. Objective - To develop a reliable reverse-phase HPLC chromatographic method for the analysis of phenolic compounds in both B. dracunculifolia raw material and its hydroalcoholic extracts. Methodology - The method utilised a C-18 CLC-ODS (M) (4.6 x 250 mm) column with nonlinear gradient elution and UV detection at 280 nm. A procedure for the extraction of phenolic compounds using aqueous ethanol 90%, with the addition of veratraldehyde as the internal standard, was developed allowing the quantification of 10 compounds: caffeic acid, coumaric acid, ferulic acid, cinnamic acid, aromadendrin-4'-methyl ether, isosakuranetin, drupanin, artepillin C, baccharin and 2,2-dimethyl-6-carboxyethenyl-2H-1-benzopyran acid. Results - The developed method gave a good detection response with linearity in the range 20.83-800 mu g/mL and recovery in the range 81.25-93.20%, allowing the quantification of the analysed standards. Conclusion - The method presented good results for the following parameters: selectivity, linearity, accuracy, precision, robustness, as well as limit of detection and limit of quantitation. Therefore, this method could be considered as an analytical tool for the quality control of B. dracunculifolia raw material and its products in both cosmetic and pharmaceutical companies. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 26 条
  • [1] Akao Y, 2003, BIOL PHARM BULL, V26, P1057, DOI 10.1248/bpb.26.1057
  • [2] [Anonymous], 1997, Federal Register, V62, P27463
  • [3] Bastos JK, 2001, J SEP SCI, V24, P406, DOI 10.1002/1615-9314(20010501)24:5<406::AID-JSSC406>3.0.CO
  • [4] 2-
  • [5] Optimisation of an extraction procedure and chemical characterisation of croatian Propolis tinctures
    Cvek, J.
    Medic-Saric, M.
    Jasprica, I.
    Zubcic, S.
    Vitali, D.
    Mornar, A.
    Vedrina-Dragojevic, I.
    Tomic, S.
    [J]. PHYTOCHEMICAL ANALYSIS, 2007, 18 (05) : 451 - 459
  • [6] In-vitro trypanocidal activit evaluation of crude y extract and isolated compounds from Baccharis dracunculifolia D.C. (Asteraceae)
    da Silva, AA
    Bueno, PCP
    Gregório, LE
    Silva, MLAE
    Albuquerque, S
    Bastos, JK
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (09) : 1195 - 1199
  • [7] A reliable quantitative method for the analysis of phenolic compounds in Brazilian propolis by reverse phase high performance liquid chromatography
    de Sousa, Joao P. B.
    Bueno, Paula C. P.
    Gregorio, Luiz E.
    da Silva Filho, Ademar A.
    Furtado, Niege A. J. C.
    de Sousa, Marcia L.
    Bastos, Jairo K.
    [J]. JOURNAL OF SEPARATION SCIENCE, 2007, 30 (16) : 2656 - 2665
  • [8] Filho AADS, 2008, Z NATURFORSCH C, V63, P40
  • [9] Klopell FC, 2007, Z NATURFORSCH C, V62, P537
  • [10] Comparative evaluation of in-vitro effects of Brazilian green propolis and Baccharis dracunculifolia extracts on cariogenic factors of Streptococcus mutans
    Leitao, DPD
    da Silva, AA
    Polizello, ACM
    Bastos, JK
    Spadaro, ACC
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (11) : 1834 - 1839